Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 17, 2005
[A COX-2 inhibitor suppresses esophageal inflammation-metaplasia-adenocarcinoma sequence in rats]Koichi Miwa, Katsunobu Oyama, Takashi Fujimura
Clinical Calcium|November 30, 2018
[Secondary osteoporosis. Bone metabolism disorder after gastrointestinal surgery.]Katsunobu Oyama, Sachio Fushida, Jun Kinoshita, et al.
World Journal of Gastroenterology|March 23, 2006
Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experienceTakashi Fujimura, Tetsuo Ohta, Katsunobu Oyama, et al.
Hepato-Gastroenterology|June 22, 2005
Right hepatic duct opening into the cystic duct: the role of pre- and intraoperative cholangiographyMasato Kayahara, Katsunobu Oyama, Hirohisa Kitagawa, et al.
Journal of Gastrointestinal Cancer|November 26, 2008
Cyclooxygenase-2 (COX-2) in carcinogenesis and selective COX-2 inhibitors for chemoprevention in gastrointestinal cancersTakashi Fujimura, Tetsuo Ohta, Katsunobu Oyama, et al.
Anti-Cancer Drugs|June 23, 2009
Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastasesSachio Fushida, Takashi Fujimura, Katsunobu Oyama, et al.
Nihon Geka Gakkai Zasshi|March 6, 2013
[Lymph node micrometastases in gastric cancer]Takashi Fujimura, Tomoya Tsukada, Jun Kinoshita, et al.
Clinical Calcium|October 28, 2015
[Bone metabolic disorder after gastrectomy]Katsunobu Oyama, Yuki Higashi, Tomoya Tsukada, et al.
Hepato-Gastroenterology|March 30, 2011
Neoadjuvant chemotherapy combining docetaxel, cisplatin and S-1 in gastric cancer with para-aortic lymph node metastases: report of five casesSachio Fushida, Takashi Fujimura, Katsunobu Oyama, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|August 7, 2007
[Cyclooxygenase (COX)-2 expression in a rat duodenoesophageal reflux model and chemoprevention of adenocarcinoma by the selective COX-2 inhibitor nimesulide]Katsunobu Oyama, Takashi Fujimura, Itasu Ninomiya, et al.
Pageof 13